We Believe in Public Private Partnership with People
By K N Bhagat, Managing Trustee, OTTET The Government cannot by itself provide all the conveniences without the cooperation of people. While individual effort […]
Tags: biomedical devices, health, Health Informatics, Health informatics in China, Health/Medical/Pharmaceuticals, healthcare, healthcare services, Information science, Labor, Lucknow, Medicare, medicine, National Resource Center, National University of Singapore public private partnership project, Public Private Partnership, quality healthcare services, School of Telemedicine & Biomedical Informatics, science, SGPGI, Skill, Social Issues, Technology, telehealth, telemedicine
Technology that Cares
Indias healthcare sector is in a dynamic phase of growth but technology must work towards affordable healthcare By Dhirendra Pratap […]
Trivitron Healthcare
Dr GSK Velu Managing Director Company name: Trivitron Group of Companies Corporate Headquarters No. 15, IV Street, Abhiramapuram, Chennai – […]
“The Government is seriously engaged in developing an indigenous medical device industry” : Dr. T Ramasami, Department of Science and Technology, Government of India, India
As the Secretary of Department of Science and Technology, Government of India, Dr. T Ramasami, has been actively engaged in the development of policies and programs for science and research activities.
Engineering Bio-Medical Marvels : Dr. Rajat Aggarwal, Implants, University of Southern California
In addition to the routine clinical work, Dr. Agarwal is involved in the Artificial Retinal Implant project, being carried out in collaboration with Texas Instruments, which aims at developing a complex artificial epiretinal device in patients with advanced retinitis pigmentosa and age-related macular degeneration, which will help these patients see again.
SRIT forms a JV Company in Australia
Sobha Renaissance Information Technology (SRIT) have announced its Joint Venture (JV) with Capital Technic Group (CTG), an Australian Management Consulting & Services firm. The joint-venture capitalized at Australian $2.5m aims to produce $7.5m in annual revenues by the second year and ramping up to $65m by the fifth.
